Literature DB >> 8289355

Importance of amino acid 101 within capsid protein VP1 for modulation of Theiler's virus-induced disease.

Y Wada1, M L Pierce, R S Fujinami.   

Abstract

We constructed a Theiler's virus mutant designated DA3304, in which the amino acid at position 101 of VP1 was changed from a threonine to an alanine. Because of this single amino acid change, DA3304 could still produce a biphasic central nervous system disease similar to that produced by the wild-type DA virus. However, DA3304 was significantly attenuated in both the acute and the chronic phases and induced smaller demyelinating lesions than the wild-type DA virus. The data are most compatible with the attenuated phenotype in DA3304 being due to the change of binding efficiency between the virus and receptor resulting from the physical alteration at the mutation site.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8289355      PMCID: PMC236565          DOI: 10.1128/JVI.68.2.1219-1223.1994

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  The 5' noncoding sequences from a less virulent Theiler's virus dramatically attenuate GDVII neurovirulence.

Authors:  H L Lipton; M Calenoff; P Bandyopadhyay; S D Miller; M C Dal Canto; S Gerety; K Jensen
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination.

Authors:  H L Lipton
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

3.  Temperature-sensitive poliovirus mutant fails to cleave VP0 and accumulates provirions.

Authors:  S R Compton; B Nelsen; K Kirkegaard
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

4.  Chimeric cDNA studies of Theiler's murine encephalomyelitis virus neurovirulence.

Authors:  L Zhang; A Senkowski; B Shim; R P Roos
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

5.  Assembly of Theiler's virus recombinants used in mapping determinants of neurovirulence.

Authors:  A E Pritchard; K Jensen; H L Lipton
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

6.  Strains from both Theiler's virus subgroups encode a determinant for demyelination.

Authors:  J Fu; M Rodriguez; R P Roos
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

7.  Host range mutant of human immunodeficiency virus type 1: modification of cell tropism by a single point mutation at the neutralization epitope in the env gene.

Authors:  Y Takeuchi; M Akutsu; K Murayama; N Shimizu; H Hoshino
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

8.  Primary demyelination in Theiler's virus infection. An ultrastructural study.

Authors:  M C Dal Canto; H L Lipton
Journal:  Lab Invest       Date:  1975-12       Impact factor: 5.662

9.  Direct evidence of a role for amino acid 101 of VP-1 in central nervous system disease in Theiler's murine encephalomyelitis virus infection.

Authors:  A Zurbriggen; C Thomas; M Yamada; R P Roos; R S Fujinami
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

10.  Viral infection and dissemination through the olfactory pathway and the limbic system by Theiler's virus.

Authors:  Y Wada; R S Fujinami
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

View more
  18 in total

1.  Virus persistence in an animal model of multiple sclerosis requires virion attachment to sialic acid coreceptors.

Authors:  A S Manoj Kumar; Honey V Reddi; Aisha Y Kung; Mauro Dal Canto; Howard L Lipton
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

2.  Direct comparison of demyelinating disease induced by the Daniel's strain and BeAn strain of Theiler's murine encephalomyelitis virus.

Authors:  Laurie J Zoecklein; Kevin D Pavelko; Jeff Gamez; Louisa Papke; Dorian B McGavern; Daren R Ure; M Kariuki Njenga; Aaron J Johnson; Shunya Nakane; Moses Rodriguez
Journal:  Brain Pathol       Date:  2003-07       Impact factor: 6.508

3.  The immune system preferentially clears Theiler's virus from the gray matter of the central nervous system.

Authors:  M K Njenga; K Asakura; S F Hunter; P Wettstein; L R Pease; M Rodriguez
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

4.  Role of sialyloligosaccharide binding in Theiler's virus persistence.

Authors:  L Zhou; X Lin; T J Green; H L Lipton; M Luo
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B.

Authors:  I Tsunoda; Y Wada; J E Libbey; T S Cannon; F G Whitby; R S Fujinami
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

6.  Role of VP2 amino acid 141 in tropism of Theiler's virus within the central nervous system.

Authors:  N Jarousse; C Martinat; S Syan; M Brahic; A McAllister
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

7.  The leader polypeptide of Theiler's virus is essential for neurovirulence but not for virus growth in BHK cells.

Authors:  M A Calenoff; C S Badshah; M C Dal Canto; H L Lipton; M K Rundell
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

8.  Mutations that affect the tropism of DA and GDVII strains of Theiler's virus in vitro influence sialic acid binding and pathogenicity.

Authors:  Karima Jnaoui; Muriel Minet; Thomas Michiels
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

9.  TGF-beta1 suppresses T cell infiltration and VP2 puff B mutation enhances apoptosis in acute polioencephalitis induced by Theiler's virus.

Authors:  Ikuo Tsunoda; Jane E Libbey; Robert S Fujinami
Journal:  J Neuroimmunol       Date:  2007-09-04       Impact factor: 3.478

Review 10.  Evolution of cell recognition by viruses: a source of biological novelty with medical implications.

Authors:  Eric Baranowski; Carmen M Ruiz-Jarabo; Nonia Pariente; Nuria Verdaguer; Esteban Domingo
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.